5-Fluorouracil (5-FU) is widely used for treatment of advanced
colorectal cancer. However, it is common for such patients to develop resistance to
5-FU, and this drug resistance becomes a critical problem for
chemotherapy. The mechanisms underlying this resistance are largely unknown. To screen for
proteins possibly responsible for
5-FU resistance, cells resistant to
5-FU were derived from human
colon cancer cell lines and two-dimensional gel electrophoresis-based comparative proteomics was done. Two-dimensional gel electrophoresis data showed there was lower expression of the alpha subunit of mitochondrial F(1)F(0)-ATP synthase (
ATP synthase) in 5-FU-resistant cells compared with parent cells. Western blotting showed that expression of other
ATP synthase complex subunits was also lower in 5-FU-resistant cell lines and that these resistant cells also showed decreased
ATP synthase activity and reduced intracellular
ATP content. The
ATP synthase inhibitor,
oligomycin A, strongly antagonized 5-FU-induced suppression of cell proliferation. When
5-FU sensitivity was compared with
ATP synthase activity in six different human
colon cancer cell lines, a positive correlation has been found. Furthermore, suppressed
ATP synthase d-subunit expression by
siRNA transfection increased cell viability in the presence of
5-FU. Bioenergetic dysfunction of mitochondria has been reported as a hallmark of many types of
cancers (i.e., down-regulation of
ATP synthase beta-subunit expression in liver, kidney, colon, squamous oesophageal, and lung
carcinomas, as well as in breast and gastric
adenocarcinomas). Our findings show that
ATP synthase down-regulation may not only be a bioenergetic signature of
colorectal carcinomas but may also lead to cellular events responsible for
5-FU resistance.